Tag Archives: Boston University (BU)

D-Wave Systems demonstrates quantum advantage on optimization problems with a 5,000-qubit programmable spin glass

This May 17, 2023 article by Ingrid Fadelli for phys.org describes quantum research performed by D-Wave Systems (a company in Vancouver, Canada) and Boston University (Massachusetts, US), Note: Links have been removed,

Over the past decades, researchers and companies worldwide have been trying to develop increasingly advanced quantum computers. The key objective of their efforts is to create systems that will outperform classical computers on specific tasks, which is also known as realizing “quantum advantage.”

A research team at D-Wave Inc., a quantum computing company, recently created a new quantum computing system that outperforms classical computing systems on optimization problems. This system, introduced in a paper in Nature, is based on a programmable spin glass with 5,000 qubits (the quantum equivalents of bits in classical computing).

“This work validates the original hypothesis behind quantum annealing, coming full circle from some seminal experiments conducted in the 1990s,” Andrew D. King, one of the researchers who carried out the study, told Phys.org.

“These original experiments took chunks of spin-glass alloy and subjected them to varying magnetic fields, and the observations suggested that if we made a programmable quantum spin glass, it could drive down to low-energy states of optimization problems faster than analogous classical algorithms. A Science paper published in 2014 tried to verify this on a D-Wave Two processor, but no speedup was found.”

“This is a ‘full circle’ moment, in the sense that we have verified and extended the hypothesis of the UChicago [University of Chicago] and NEC [Nippon Electric Company] researchers; quantum annealing shows a scaling advantage over simulated thermal annealing,” King said. “Ours is the largest programmable quantum simulation ever performed; reproducing it classically is way beyond the reach of known methods.”

“We have a clear view of quantum effects and very clear evidence, both theoretical and experimental, that the quantum effects are conferring a computational scaling advantage over classical methods,” King said. “We want to highlight the difference between this original definition of quantum advantage and the fact that it is sometimes used as a stand-in term for quantum supremacy, which we have not demonstrated. [emphases mine] Gate-model quantum computers have not shown any capabilities approaching this for optimization, and I personally don’t believe they ever will.”

“For a long time, it was subject for debate whether or not coherent quantum dynamics were playing any role at all in quantum annealing,” King said. “While this controversy has been rebuked by previous works, this new research is the clearest demonstration yet, by far.”

An April 19, 2023 D-Wave Systems news release, which seems to have been the basis for Fadelli’s article, provides more detail in a release that functions as a research announcement and a sales tool, Note: Links have been removed,

D-Wave Quantum Inc. (NYSE: QBTS), a leader in quantum computing systems, software, and services—and the only provider building both annealing and gate-model quantum computers, today published a peer-reviewed milestone paper showing the performance of its 5,000 qubit Advantage™ quantum computer is significantly faster than classical compute on 3D spin glass optimization problems, an intractable class of optimization problems. This paper also represents the largest programmable quantum simulation reported to date.

The paper—a collaboration between scientists from D-Wave and Boston University—entitled “Quantum critical dynamics in a 5,000-qubit programmable spin glass,” was published in the peer-reviewed journal Nature today and is available here. Building upon research conducted on up to 2,000 qubits last September, the study shows that the D-Wave quantum processor can compute coherent quantum dynamics in large-scale optimization problems. This work was done using D-Wave’s commercial-grade annealing-based quantum computer, which is accessible for customers to use today.

With immediate implications to optimization, the findings show that coherent quantum annealing can improve solution quality faster than classical algorithms. The observed speedup matches the theory of coherent quantum annealing and shows​ a direct connection between coherence and the core computational power of quantum annealing.

“This research marks a significant achievement for quantum technology, as it demonstrates a computational advantage over classical approaches for an intractable class of optimization problems,” said Dr. Alan Baratz, CEO of D-Wave. “For those seeking evidence of quantum annealing’s unrivaled performance, this work offers definitive proof.

This work supports D-Wave’s ongoing commitment to relentless scientific innovation and product delivery, as the company continues development on its future annealing and gate model quantum computers. To date, D-Wave has brought to market five generations of quantum computers and launched an experimental prototype of its sixth-generation machine, the Advantage2™ system, in June 2022. The full Advantage2 system is expected to feature 7,000+ qubits, 20-way connectivity and higher coherence to solve even larger and more complex problems. Read more about the research in our Medium post here.

Paper’s Authors and Leading Industry Voices Echo Support

“This is an important advance in the study of quantum phase transitions on quantum annealers. It heralds a revolution in experimental many-body physics and bodes well for practical applications of quantum computing,” said Wojciech Zurek, theoretical physicist at Los Alamos National Laboratory and leading authority on quantum theory. Dr. Zurek is widely renowned for his groundbreaking contribution to our understanding of the early universe as well as condensed matter systems through the discovery of the celebrated Kibble-Zurek mechanism. This mechanism underpins the physics behind the experiment reported in this paper. “The same hardware that has already provided useful experimental proving ground for quantum critical dynamics can be also employed to seek low-energy states that assist in finding solutions to optimization problems.”

“Disordered magnets, such as spin glasses, have long functioned as model systems for testing solvers of complex optimization problems,” said Gabriel Aeppli, professor of physics at ETH Zürich and EPF Lausanne, and head of the Photon Science Division of the Paul Scherrer Institut. Professor Aeppli coauthored the first experimental paper demonstrating advantage of quantum annealing over thermal annealing in reaching ground state of disordered magnets. “This paper gives evidence that the quantum dynamics of a dedicated hardware platform are faster than for known classical algorithms to find the preferred, lowest energy state of a spin glass, and so promises to continue to fuel the further development of quantum annealers for dealing with practical problems.”

“As a physicist who has built my career on computer simulations of quantum systems, it has been amazing to experience first-hand the transformative capabilities of quantum annealing devices,” said Anders Sandvik, professor of physics at Boston University and a coauthor of the paper. “This paper already demonstrates complex quantum dynamics on a scale beyond any classical simulation method, and I’m very excited about the expected enhanced performance of future devices. I believe we are now entering an era when quantum annealing becomes an essential tool for research on complex systems.”

“This work marks a major step towards large-scale quantum simulations of complex materials,” said Hidetoshi Nishimori, Professor, Institute of Innovative Research, Tokyo Institute of Technology and one of the original inventors of quantum annealing. “We can now expect novel physical phenomena to be revealed by quantum simulations using quantum annealing, ultimately leading to the design of materials of significant societal value.”

“This represents some of the most important experimental work ever performed in quantum optimization,” said Dr. Andrew King, director of performance research at D-Wave. “We’ve demonstrated a speedup over simulated annealing, in strong agreement with theory, providing high-quality solutions for large-scale problems. This work shows clear evidence of quantum dynamics in optimization, which we believe paves the way for even more complex problem-solving using quantum annealing in the future. The work exhibits a programmable realization of lab experiments that originally motivated quantum annealing 25 years ago.”

“Not only is this the largest demonstration of quantum simulation to date, but it also provides the first experimental evidence, backed by theory, that coherent quantum dynamics can accelerate the attainment of better solutions in quantum annealing,” said Mohammad Amin, fellow, quantum algorithms and systems, at D-Wave. “The observed speedup can be attributed to complex critical dynamics during quantum phase transition, which cannot be replicated by classical annealing algorithms, and the agreement between theory and experiment is remarkable. We believe these findings have significant implications for quantum optimization, with practical applications in addressing real-world problems.”

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software, and services, and is the world’s first commercial supplier of quantum computers—and the only company building both annealing quantum computers and gate-model quantum computers. Our mission is to unlock the power of quantum computing today to benefit business and society. We do this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. D-Wave’s technology is being used by some of the world’s most advanced organizations, including Volkswagen, Mastercard, Deloitte, Davidson Technologies, ArcelorMittal, Siemens Healthineers, Unisys, NEC Corporation, Pattison Food Group Ltd., DENSO, Lockheed Martin, Forschungszentrum Jülich, University of Southern California, and Los Alamos National Laboratory.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which statements are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. We caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, which are subject to a number of risks. Forward-looking statements in this press release include, but are not limited to, statements regarding the impact of the results of this study; the company’s Advantage2™ experimental prototype; and the potential for future problem-solving using quantum annealing. We cannot assure you that the forward-looking statements in this press release will prove to be accurate. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including general economic conditions and other risks, our ability to expand our customer base and the customer adoption of our solutions, and the uncertainties and factors set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in D-Wave Quantum Inc.’s Form S-4 Registration Statement, as amended, previously filed with the Securities and Exchange Commission, as well as factors associated with companies, such as D-Wave, that are engaged in the business of quantum computing, including anticipated trends, growth rates, and challenges in those businesses and in the markets in which they operate; the outcome of any legal proceedings that may be instituted against us; risks related to the performance of our business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and or timing thereof; the performance of the our products; the effects of competition on our business; the risk that we will need to raise additional capital to execute our business plan, which may not be available on acceptable terms or at all; the risk that we may never achieve or sustain profitability; the risk that we are unable to secure or protect our intellectual property; volatility in the price of our securities; and the risk that our securities will not maintain the listing on the NYSE. Furthermore, if the forward-looking statements contained in this press release prove to be inaccurate, the inaccuracy may be material. In addition, you are cautioned that past performance may not be indicative of future results. In light of the significant uncertainties in these forward-looking statements, you should not place undue reliance on these statements in making an investment decision or regard these statements as a representation or warranty by any person we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release.

Here’s a link to and a citation for the paper,

Quantum critical dynamics in a 5,000-qubit programmable spin glass by Andrew D. King, Jack Raymond, Trevor Lanting, Richard Harris, Alex Zucca, Fabio Altomare, Andrew J. Berkley, Kelly Boothby, Sara Ejtemaee, Colin Enderud, Emile Hoskinson, Shuiyuan Huang, Eric Ladizinsky, Allison J. R. MacDonald, Gaelen Marsden, Reza Molavi, Travis Oh, Gabriel Poulin-Lamarre, Mauricio Reis, Chris Rich, Yuki Sato, Nicholas Tsai, Mark Volkmann, Jed D. Whittaker, Jason Yao, Anders W. Sandvik & Mohammad H. Amin. Nature volume 617, pages 61–66 (2023) DOI: https://doi.org/10.1038/s41586-023-05867-2 Published: 19 April 2023 Issue Date: 04 May 2023

This paper is behind a paywall but there is an open access version on the arxiv website which means that it has had some peer review but may differ from the version in Nature.

Research communicated by puppets

Yes, there’s protein folding as explained by puppets,

An April 25, 2019 article by Madeleine O’Keefe for BU (Boston University) Today describes both the course “Thinking through Puppets and Performing Objects: Using Theatrical Tools to Communicate the Complex, the Abstract, and the Technical” and a then upcoming Puppet Slam performance (Note: Links have been removed),

Thinking through Puppets is the brainchild of Felice Amato, a College of Fine Arts assistant professor of art education and a Pardee Center for the Study of the Longer-Range Future faculty associate, and Anna Panszczyk (CAS’97), a College of Arts & Sciences Writing Program senior lecturer.

The course is part of the BU Cross-College Challenge (XCC), the Hub’s signature project-based, one-semester four-credit elective course open to juniors and seniors from all 10 undergraduate schools and colleges. It fulfills four Hub units: Creativity/Innovation, Oral Communication, Research and Information Literacy, and Teamwork/Collaboration.

Amato previously taught K-12 art in public schools and focused her doctoral work on puppetry. Panszczyk focuses on children’s literature and culture in her writing, and says she was interested in working with Amato to see how a puppet project could help students develop the aforementioned four Hub skills.

The course attracted six undergraduates, … . Suddenly, they were thrust into a world of cutting, crafting, sewing, gluing, shaping, and molding. They worked with fabric, wood, paper, everyday trash, and more—even M&Ms.

“It was definitely challenging,” Kasanaa [Vinamre Kasanaa. senior at BU] acknowledges. “Taking the leap from our passive classes, which are information-intensive—you get the information, you regurgitate it out on paper, you write, you debate—it’s all abstract.…Tapping your fingers on the screen is not a replacement for craftsmanship, where you’re using your hands. So that’s the one thing that we all were able to learn, because most of us made our own puppets and made these things by ourselves.”

An important aspect of the XCC courses is working on real-world projects with a variety of on-campus and community clients. As the culmination of Thinking through Puppets, Amato, Panszczyk, and their students produced puppet slams …

What exactly is a puppet slam? Amato defines it as “a series of short experimental pieces,” each typically about three minutes long. Puppet slams got their launch at Puppet Showplace Theater, but have become so popular that they now are held all over the world. Heather Henson, daughter of Jim Henson, the Emmy-winning creator of the Muppets, supports a national Puppet Slam Network.

Devyani Chhetri’s March 26, 2020 article for BU Hub updates the story with a description of the 2020 class’s Puppet Slam,

They say that actions speak louder than words. Nothing was more true when XCC students took the stage last Friday to reveal the anxieties of the world borne from issues such as climate change, sexual harassment and immigration— through puppets.

In …, “Puppets against Climate Change”, two puppets are seated in a car and driving around puppet city when they ignore a sign that said ‘no dumping’ and throw trash out of the car.

With Rindner’s [Alexis Rindner, BU student] exaggerated puppet voice leaving the audience in splits, the two puppets are struck soon after by a ‘trash’ comet that decimates the puppet planet.

The humor of the moment gives way to a grim montage of a destroyed planet when the ghosts of the puppets go over the years of excesses where deforestation and pollution in the name of progress led to global warming and the puppet planet’s eventual demise.

You can find the Puppet Slam Network here. The homepage includes a map of various Puppet Slam members.

There are three network members in Canada: Vancouver International Puppet Festival (VIPF) in British Columbia, Calgary Animated Objects Society (CAOS) in Alberta, and the Winnipeg Puppet Slam in Manitoba.

As far as I’m aware, none of the three Canadian members are focused on explicitly communicating research in the manner of the Boston University programme.

Fishes ‘talk’ and ‘sing’

This posting started out with two items and then, it became more. If you’re interested in marine bioacoustics especially the work that’s been announced in the last four months, read on.

Fish songs

This item is about how fish sounds (songs) signify successful coral reef restoration got coverage on BBC (British Broadcasting Corporation), CBC (Canadian Broadcasting Corporation) and elsewhere. This video is courtesy of the Guardian Newspaper,

Whoops and grunts: ‘bizarre’ fish songs raise hopes for coral reef recovery https://www.theguardian.com/environme…

A December 8, 2021 University of Exeter press release (also on EurekAlert) explains why the sounds give hope (Note: Links have been removed),

Newly discovered fish songs demonstrate reef restoration success

Whoops, croaks, growls, raspberries and foghorns are among the sounds that demonstrate the success of a coral reef restoration project.

Thousands of square metres of coral are being grown on previously destroyed reefs in Indonesia, but previously it was unclear whether these new corals would revive the entire reef ecosystem.

Now a new study, led by researchers from the University of Exeter and the University of Bristol, finds a heathy, diverse soundscape on the restored reefs.

These sounds – many of which have never been recorded before – can be used alongside visual observations to monitor these vital ecosystems.

“Restoration projects can be successful at growing coral, but that’s only part of the ecosystem,” said lead author Dr Tim Lamont, of the University of Exeter and the Mars Coral Reef Restoration Project, which is restoring the reefs in central Indonesia.

“This study provides exciting evidence that restoration really works for the other reef creatures too – by listening to the reefs, we’ve documented the return of a diverse range of animals.”

Professor Steve Simpson, from the University of Bristol, added: “Some of the sounds we recorded are really bizarre, and new to us as scientists.  

“We have a lot still to learn about what they all mean and the animals that are making them. But for now, it’s amazing to be able to hear the ecosystem come back to life.”

The soundscapes of the restored reefs are not identical to those of existing healthy reefs – but the diversity of sounds is similar, suggesting a healthy and functioning ecosystem.

There were significantly more fish sounds recorded on both healthy and restored reefs than on degraded reefs.

This study used acoustic recordings taken in 2018 and 2019 as part of the monitoring programme for the Mars Coral Reef Restoration Project.

The results are positive for the project’s approach, in which hexagonal metal frames called ‘Reef Stars’ are seeded with coral and laid over a large area. The Reef Stars stabilise loose rubble and kickstart rapid coral growth, leading to the revival of the wider ecosystem.  

Mochyudho Prasetya, of the Mars Coral Reef Restoration Project, said: “We have been restoring and monitoring these reefs here in Indonesia for many years. Now it is amazing to see more and more evidence that our work is helping the reefs come back to life.”

Professor David Smith, Chief Marine Scientist for Mars Incorporated, added: “When the soundscape comes back like this, the reef has a better chance of becoming self-sustaining because those sounds attract more animals that maintain and diversify reef populations.”

Asked about the multiple threats facing coral reefs, including climate change and water pollution, Dr Lamont said: “If we don’t address these wider problems, conditions for reefs will get more and more hostile, and eventually restoration will become impossible.

“Our study shows that reef restoration can really work, but it’s only part of a solution that must also include rapid action on climate change and other threats to reefs worldwide.”

The study was partly funded by the Natural Environment Research Council and the Swiss National Science Foundation.

Here’s a link to and a citation for the paper,

The sound of recovery: Coral reef restoration success is detectable in the soundscape by Timothy A. C. Lamont, Ben Williams, Lucille Chapuis, Mochyudho E. Prasetya, Marie J. Seraphim, Harry R. Harding, Eleanor B. May, Noel Janetski, Jamaluddin Jompa, David J. Smith, Andrew N. Radford, Stephen D. Simpson. Journal of Applied Ecology DOI: https://doi.org/10.1111/1365-2664.14089 First published: 07 December 2021

This paper is open access.

You can find the MARS Coral Reef Restoration Project here.

Fish talk

There is one item here. This research from Cornell University also features the sounds fish make. It’s no surprise given the attention being given to sound that the Cornell Lab of Ornithology is involved. In addition to the lab’s main focus, birds, many other animal sounds are gathered too.

A January 27, 2022 Cornell University news release (also on EurekAlert) describes ‘fish talk’,

There’s a whole lot of talking going on beneath the waves. A new study from Cornell University finds that fish are far more likely to communicate with sound than generally thought—and some fish have been doing this for at least 155 million years. These findings were just published in the journal Ichthyology & Herpetology.

“We’ve known for a long time that some fish make sounds,” said lead author Aaron Rice, a researcher at the K. Lisa Yang Center for Conservation Bioacoustics at the Cornell Lab of Ornithology [emphasis mine]. “But fish sounds were always perceived as rare oddities. We wanted to know if these were one-offs or if there was a broader pattern for acoustic communication in fishes.”

The authors looked at a branch of fishes called the ray-finned fishes. These are vertebrates (having a backbone) that comprise 99% of the world’s known species of fishes. They found 175 families that contain two-thirds of fish species that do, or are likely to, communicate with sound. By examining the fish family tree, study authors found that sound was so important, it evolved at least 33 separate times over millions of years.

“Thanks to decades of basic research on the evolutionary relationships of fishes, we can now explore many questions about how different functions and behaviors evolved in the approximately 35,000 known species of fishes,” said co-author William E. Bemis ’76, Cornell professor of ecology and evolutionary biology in the College of Agriculture and Life Sciences. “We’re getting away from a strictly human-centric way of thinking. What we learn could give us some insight on the drivers of sound communication and how it continues to evolve.”

The scientists used three sources of information: existing recordings and scientific papers describing fish sounds; the known anatomy of a fish—whether they have the right tools for making sounds, such as certain bones, an air bladder, and sound-specific muscles; and references in 19th century literature before underwater microphones were invented.
 
“Sound communication is often overlooked within fishes, yet they make up more than half of all living vertebrate species,” said Andrew Bass, co-lead author and the Horace White Professor of Neurobiology and Behavior in the College of Arts and Sciences. “They’ve probably been overlooked because fishes are not easily heard or seen, and the science of underwater acoustic communication has primarily focused on whales and dolphins. But fishes have voices, too!”
 
Listen:

Oyster ToadfishWilliam Tavolga, Macaulay Library

Longspine squirrelfishHoward Winn, Macaulay Library 

Banded drumDonald Batz, Macaulay Library

Midshipman, Andrew Bass, Macaulay Library

What are the fish talking about? Pretty much the same things we all talk about—sex and food. Rice says the fish are either trying to attract a mate, defend a food source or territory, or let others know where they are. Even some of the common names for fish are based on the sounds they make, such as grunts, croakers, hog fish, squeaking catfish, trumpeters, and many more.
 
Rice intends to keep tracking the discovery of sound in fish species and add them to his growing database (see supplemental material, Table S1)—a project he began 20 years ago with study co-authors Ingrid Kaatz ’85, MS ’92, and Philip Lobel, a professor of biology at Boston University. Their collaboration has continued and expanded since Rice came to Cornell.
 
“This introduces sound communication to so many more groups than we ever thought,” said Rice. “Fish do everything. They breathe air, they fly, they eat anything and everything—at this point, nothing would surprise me about fishes and the sounds that they can make.”

The research was partly funded by the National Science Foundation, the U.S. Bureau of Ocean Energy Management, the Tontogany Creek Fund, and the Cornell Lab of Ornithology.

I’ve embedded one of the audio files, Oyster Toadfish (William Tavolga) here,

Here’s a link to and a citation for the paper,

Evolutionary Patterns in Sound Production across Fishes by Aaron N. Rice, Stacy C. Farina, Andrea J. Makowski, Ingrid M. Kaatz, Phillip S. Lobel, William E. Bemis, Andrew H. Bass. Ichthyology & Herpetology, 110(1):1-12 (2022) DOI: https://doi.org/10.1643/i2020172 20 January 2022

This paper is open access.

Marine sound libraries

Thanks to Aly Laube’s March 2, 2022 article on the DailyHive.com, I learned of Kieran Cox’s work at the University of Victoria and FishSounds (Note: Links have been removed),

Fish have conversations and a group of researchers made a website to document them. 

It’s so much fun to peruse and probably the good news you need. Listen to a Bocon toadfish “boop” or this sablefish tick, which is slightly creepier, but still pretty cool. This streaked gurnard can growl, and this grumpy Atlantic cod can grunt.

The technical term for “fishy conversations” is “marine bioacoustics,” which is what Kieran Cox specializes in. They can be used to track, monitor, and learn more about aquatic wildlife.

The doctor of marine biology at the University of Victoria co-authored an article about fish sounds in Reviews in Fish Biology and Fisheries called “A Quantitative Inventory of Global Soniferous Fish Diversity.”

It presents findings from his process, helping create FishSounds.net. He and his team looked over over 3,000 documents from 834 studies to put together the library of 989 fish species.

A March 2, 2022 University of Victoria news release provides more information about the work and the research team (Note: Links have been removed),

Fascinating soundscapes exist beneath rivers, lakes and oceans. An unexpected sound source are fish making their own unique and entertaining noise from guttural grunts to high-pitched squeals. Underwater noise is a vital part of marine ecosystems, and thanks to almost 150 years of researchers documenting those sounds we know hundreds of fish species contribute their distinctive sounds. Although fish are the largest and most diverse group of sound-producing vertebrates in water, there was no record of which fish species make sound and the sounds they produce. For the very first time, there is now a digital place where that data can be freely accessed or contributed to, an online repository, a global inventory of fish sounds.

Kieran Cox co-authored the published article about fish sounds and their value in Reviews in Fish Biology and Fisheries while completing his Ph.D in marine biology at the University of Victoria. Cox recently began a Liber Ero post-doctoral collaboration with Francis Juanes that aims to integrate marine bioacoustics into the conservation of Canada’s oceans. Liber Ero program is devoted to promoting applied and evidence-based conservation in Canada.

The international group of researchers includes UVic, the University of Florida, Universidade de São Paulo, and Marine Environmental Research Infrastructure for Data Integration and Application Network (MERIDIAN) [emphasis mine] have launched the first ever, dedicated website focused on fish and their sounds: FishSounds.net. …

According to Cox, “This data is absolutely critical to our efforts. Without it, we were having a one-sided conversation about how noise impacts marine life. Now we can better understand the contributions fish make to soundscapes and examine which species may be most impacted by noise pollution.” Cox, an avid scuba diver, remembers his first dive when the distinct sound of parrotfish eating coral resonated over the reef, “It’s thrilling to know we are now archiving vital ecological information and making it freely available to the public, I feel like my younger self would be very proud of this effort.” …

There’s also a March 2, 2022 University of Florida news release on EurekAlert about FishSounds which adds more details about the work (Note: Links have been removed),

Cows moo. Wolves howl. Birds tweet. And fish, it turns out, make all sorts of ruckus.

“People are often surprised to learn that fish make sounds,” said Audrey Looby, a doctoral candidate at the University of Florida. “But you could make the case that they are as important for understanding fish as bird sounds are for studying birds.”

The sounds of many animals are well documented. Go online, and you’ll find plenty of resources for bird calls and whale songs. However, a global library for fish sounds used to be unheard of.

That’s why Looby, University of Victoria collaborator Kieran Cox and an international team of researchers created FishSounds.net, the first online, interactive fish sounds repository of its kind.

“There’s no standard system yet for naming fish sounds, so our project uses the sound names researchers have come up with,” Looby said. “And who doesn’t love a fish that boops?”

The library’s creators hope to add a feature that will allow people to submit their own fish sound recordings. Other interactive features, such as a world map with clickable fish sound data points, are also in the works.

Fish make sound in many ways. Some, like the toadfish, have evolved organs or other structures in their bodies that produce what scientists call active sounds. Other fish produce incidental or passive sounds, like chewing or splashing, but even passive sounds can still convey information.

Scientists think fish evolved to make sound because sound is an effective way to communicate underwater. Sound travels faster under water than it does through air, and in low visibility settings, it ensures the message still reaches an audience.

“Fish sounds contain a lot of important information,” said Looby, who is pursuing a doctorate in fisheries and aquatic sciences at the UF/IFAS College of Agricultural and Life Sciences. “Fish may communicate about territory, predators, food and reproduction. And when we can match fish sounds to fish species, their sounds are a kind of calling card that can tell us what kinds of fish are in an area and what they are doing.”

Knowing the location and movements of fish species is critical for environmental monitoring, fisheries management and conservation efforts. In the future, marine, estuarine or freshwater ecologists could use hydrophones — special underwater microphones — to gather data on fish species’ whereabouts. But first, they will need to be able to identify which fish they are hearing, and that’s where the fish sounds database can assist.

FishSounds.net emerged from the research team’s efforts to gather and review the existing scientific literature on fish sounds. An article synthesizing that literature has just been published in Reviews in Fish Biology and Fisheries.

In the article, the researchers reviewed scientific reports of fish sounds going back almost 150 years. They found that a little under a thousand fish species are known to make active sounds, and several hundred species were studied for their passive sounds. However, these are probably both underestimates, Cox explained.

Here’s a link to and a citation for the paper,

A quantitative inventory of global soniferous fish diversity by Audrey Looby, Kieran Cox, Santiago Bravo, Rodney Rountree, Francis Juanes, Laura K. Reynolds & Charles W. Martin. Reviews in Fish Biology and Fisheries (2022) DOI: https://doi.org/10.1007/s11160-022-09702-1 Published 18 February 2022

This paper is behind a paywall.

Finally, there’s GLUBS. A comprehensive February 27, 2022 Rockefeller University news release on EurekAlert announces a proposal for the Global Library of Underwater Biological Sounds (GLUBS), Note 1: Links have been removed; Note 2: If you’re interested in the topic, I recommend reading either the original February 27, 2022 Rockefeller University news release with its numerous embedded images, audio files, and links to marine audio libraries,

Of the roughly 250,000 known marine species, scientists think all ~126 marine mammals emit sounds – the ‘thwop’, ‘muah’, and ‘boop’s of a humpback whale, for example, or the boing of a minke whale. Audible too are at least 100 invertebrates, 1,000 of the world’s 34,000 known fish species, and likely many thousands more.

Now a team of 17 experts from nine countries has set a goal [emphasis mine] of gathering on a single platform huge collections of aquatic life’s tell-tale sounds, and expanding it using new enabling technologies – from highly sophisticated ocean hydrophones and artificial intelligence learning systems to phone apps and underwater GoPros used by citizen scientists.

The Global Library of Underwater Biological Sounds, “GLUBS,” will underpin a novel non-invasive, affordable way for scientists to listen in on life in marine, brackish and freshwaters, monitor its changing diversity, distribution and abundance, and identify new species. Using the acoustic properties of underwater soundscapes can also characterize an ecosystem’s type and condition.

“A database of unidentified sounds is, in some ways, as important as one for known sources,” the scientists say. “As the field progresses, new unidentified sounds will be collected, and more unidentified sounds can be matched to species.”

This can be “particularly important for high-biodiversity systems such as coral reefs, where even a short recording can pick up multiple animal sounds.”

Existing libraries of undersea sounds (several of which are listed with hyperlinks below) “often focus on species of interest that are targeted by the host institute’s researchers,” the paper says, and several are nationally-focussed. Few libraries identify what is missing from their catalogs, which the proposed global library would.

“A global reference library of underwater biological sounds would increase the ability for more researchers in more locations to broaden the number of species assessed within their datasets and to identify sounds they personally do not recognize,” the paper says.

The scientists note that listening to the sea has revealed great whales swimming in unexpected places, new species and new sounds.

With sound, “biologically important areas can be mapped; spawning grounds, essential fish habitat, and migration pathways can be delineated…These and other questions can be queried on broader scales if we have a global catalog of sounds.”

Meanwhile, comparing sounds from a single species across broad areas and times helps understand their diversity and evolution.

Numerous marine animals are cosmopolitan, the paper says, “either as wide-roaming individuals, such as the great whales, or as broadly distributed species, such as many fishes.”

Fin whale calls, for example, can differ among populations in the Northern and Southern hemispheres, and over seasons, whereas the call of pilot whales are similar worldwide, even though their home ranges do not (or no longer) cross the equator.

Some fishes even seem to develop geographic ‘dialects’ or completely different signal structures among regions, several of which evolve over time.

Madagascar’s skunk anemonefish … , for example, produces different agonistic (fight-related) sounds than those in Indonesia, while differences in the song of humpback whales have been observed across ocean basins.

Phone apps, underwater GoPros and citizen science

Much like BirdNet and FrogID, a library of underwater biological sounds and automated detection algorithms would be useful not only for the scientific, industry and marine management communities but also for users with a general interest.

“Acoustic technology has reached the stage where a hydrophone can be connected to a mobile phone so people can listen to fishes and whales in the rivers and seas around them. Therefore, sound libraries are becoming invaluable to citizen scientists and the general public,” the paper adds.

And citizen scientists could be of great help to the library by uploading the results of, for example, the River Listening app (www.riverlistening.com), which encourages the public to listen to and record fish sounds in rivers and coastal waters.

Low-cost hydrophones and recording systems (such as the Hydromoth) are increasingly available and waterproof recreational recording systems (such as GoPros) can also collect underwater biological sounds.

Here’s a link to and a citation for the paper,

Sounding the Call for a Global Library of Underwater Biological Sounds by Miles J. G. Parsons, Tzu-Hao Lin, T. Aran Mooney, Christine Erbe, Francis Juanes, Marc Lammers, Songhai Li, Simon Linke, Audrey Looby, Sophie L. Nedelec, Ilse Van Opzeeland, Craig Radford, Aaron N. Rice, Laela Sayigh, Jenni Stanley, Edward Urban and Lucia Di Iorio. Front. Ecol. Evol., 08 February 2022 DOI: https://doi.org/10.3389/fevo.2022.810156 Published: 08 February 2022.

This paper appears to be open access.

Tiny sponges lure coronavirus away from lung cells

This research approach looks promising as three news releases trumpeting the possibilities indicate. First, there’s the June 17, 2020 American Chemical Society (ACS) news release,

Scientists are working overtime to find an effective treatment for COVID-19, the illness caused by the new coronavirus, SARS-CoV-2. Many of these efforts target a specific part of the virus, such as the spike protein. Now, researchers reporting in Nano Letters have taken a different approach, using nanosponges coated with human cell membranes –– the natural targets of the virus –– to soak up SARS-CoV-2 and keep it from infecting cells in a petri dish.

To gain entry, SARS-CoV-2 uses its spike protein to bind to two known proteins on human cells, called ACE2 and CD147. Blocking these interactions would keep the virus from infecting cells, so many researchers are trying to identify drugs directed against the spike protein. Anthony Griffiths, Liangfang Zhang and colleagues had a different idea: making a nanoparticle decoy with the virus’ natural targets, including ACE2 and CD147, to lure SARS-CoV-2 away from cells. And to test this idea, they conducted experiments with the actual SARS-CoV-2 virus in a biosafety level 4 lab.

The researchers coated a nanoparticle polymer core with cell membranes from either human lung epithelial cells or macrophages –– two cell types infected by SARS-CoV-2. They showed that the nanosponges had ACE2 and CD147, as well as other cell membrane proteins, projecting outward from the polymer core. When administered to mice, the nanosponges did not show any short-term toxicity. Then, the researchers treated cells in a dish with SARS-CoV-2 and the lung epithelial or macrophage nanosponges. Both decoys neutralized SARS-CoV-2 and prevented it from infecting cells to a similar extent. The researchers plan to next test the nanosponges in animals before moving to human clinical trials. In theory, the nanosponge approach would work even if SARS-CoV-2 mutates to resist other therapies, and it could be used against other viruses, as well, the researchers say.

In this illustration, a nanosponge coated with a human cell membrane acts as a decoy to prevent a virus from entering cells. Credit: Adapted from Nano Letters 2020, DOI: 10.1021/acs.nanolett.0c02278

There are two research teams involved, one at Boston University and the other at the University of California at San Diego (UC San Diego or UCSD). The June 18, 2020 Boston University news release (also on EurekAlert) by Kat J. McAlpine adds more details about the research, provides some insights from the researchers, and is a little redundant if you’ve already seen the ACS news release,

Imagine if scientists could stop the coronavirus infection in its tracks simply by diverting its attention away from living lung cells? A new therapeutic countermeasure, announced in a Nano Letters study by researchers from Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) and the University of California San Diego, appears to do just that in experiments that were carried out at the NEIDL in Boston.

The breakthrough technology could have major implications for fighting the SARS-CoV-2 virus responsible for the global pandemic that’s already claimed nearly 450,000 lives and infected more than 8 million people. But, perhaps even more significantly, it has the potential to be adapted to combat virtually any virus, such as influenza or even Ebola.

“I was skeptical at the beginning because it seemed too good to be true,” says NEIDL microbiologist Anna Honko, one of the co-first authors on the study. “But when I saw the first set of results in the lab, I was just astonished.”

The technology consists of very small, nanosized drops of polymers–essentially, soft biofriendly plastics–covered in fragments of living lung cell and immune cell membranes.

“It looks like a nanoparticle coated in pieces of cell membrane,” Honko says. “The small polymer [droplet] mimics a cell having a membrane around it.”

The SARS-CoV-2 virus seeks out unique signatures of lung cell membranes and latches onto them. When that happens inside the human body, the coronavirus infection takes hold, with the SARS-CoV-2 viruses hijacking lung cells to replicate their own genetic material. But in experiments at the NEIDL, BU researchers observed that polymer droplets laden with pieces of lung cell membrane did a better job of attracting the SARS-CoV-2 virus than living lung cells. [emphasis mine]

By fusing with the SARS-CoV-2 virus better than living cells can, the nanotechnology appears to be an effective countermeasure to coronavirus infection, preventing SARS-CoV-2 from attacking cells.

“Our guess is that it acts like a decoy, it competes with cells for the virus,” says NEIDL microbiologist Anthony Griffiths, co-corresponding author on the study. “They are little bits of plastic, just containing the outer pieces of cells with none of the internal cellular machinery contained inside living cells. Conceptually, it’s such a simple idea. It mops up the virus like a sponge.”

That attribute is why the UC San Diego and BU research team call the technology “nanosponges.” Once SARS-CoV-2 binds with the cell fragments inside a nanosponge droplet–each one a thousand times smaller than the width of a human hair–the coronavirus dies. Although the initial results are based on experiments conducted in cell culture dishes, the researchers believe that inside a human body, the biodegradable nanosponges and the SARS-CoV-2 virus trapped inside them could then be disposed of by the body’s immune system. The immune system routinely breaks down and gets rid of dead cell fragments caused by infection or normal cell life cycles.

There is also another important effect that the nanosponges have in the context of coronavirus infection. Honko says nanosponges containing fragments of immune cells can soak up cellular signals that increase inflammation [emphases mine]. Acute respiratory distress, caused by an inflammatory cascade inside the lungs, is the most deadly aspect of the coronavirus infection, sending patients into the intensive care unit for oxygen or ventilator support to help them breathe.

But the nanosponges, which can attract the inflammatory molecules that send the immune system into dangerous overdrive, can help tamp down that response, Honko says. By using both kinds of nanosponges, some containing lung cell fragments and some containing pieces of immune cells, she says it’s possible to “attack the coronavirus and the [body’s] response” responsible for disease and eventual lung failure.

At the NEIDL, Honko and Griffiths are now planning additional experiments to see how well the nanosponges can prevent coronavirus infection in animal models of the disease. They plan to work closely with the team of engineers at UC San Diego, who first developed the nanosponges more than a decade ago, to tailor the technology for eventual safe and effective use in humans.

“Traditionally, drug developers for infectious diseases dive deep on the details of the pathogen in order to find druggable targets,” said Liangfang Zhang, a UC San Diego nanoengineer and leader of the California-based team, according to a UC San Diego press release. “Our approach is different. We only need to know what the target cells are. And then we aim to protect the targets by creating biomimetic decoys.”

When the novel coronavirus first appeared, the idea of using the nanosponges to combat the infection came to Zhang almost immediately. He reached out to the NEIDL for help. Looking ahead, the BU and UC San Diego collaborators believe the nanosponges can easily be converted into a noninvasive treatment.

“We should be able to drop it right into the nose,” Griffiths says. “In humans, it could be something like a nasal spray.”

Honko agrees: “That would be an easy and safe administration method that should target the appropriate [respiratory] tissues. And if you wanted to treat patients that are already intubated, you could deliver it straight into the lung.”

Griffiths and Honko are especially intrigued by the nanosponges as a new platform for treating all types of viral infections. “The broad spectrum aspect of this is exceptionally appealing,” Griffiths says. The researchers say the nanosponge could be easily adapted to house other types of cell membranes preferred by other viruses, creating many new opportunities to use the technology against other tough-to-treat infections like the flu and even deadly hemorrhagic fevers caused by Ebola, Marburg, or Lassa viruses.

“I’m interested in seeing how far we can push this technology,” Honko says.

The University of California at* San Diego has released a video illustrating the nanosponges work,

There’s also this June 17, 2020 University of California at San Diego (UC San Diego) news release (also on EurekAlert) by Ioana Patringenaru, which offers extensive new detail along with, if you’ve read one or both of the news releases in the above, a few redundant bits,

Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.

The first data describing this new direction for fighting COVID-19 were published on June 17 in the journal Nano Letters. The “nanosponges” were developed by engineers at the University of California San Diego and tested by researchers at Boston University.

The UC San Diego researchers call their nano-scale particles “nanosponges” because they soak up harmful pathogens and toxins.

In lab experiments, both the lung cell and immune cell types of nanosponges caused the SARS-CoV-2 virus to lose nearly 90% of its “viral infectivity” in a dose-dependent manner. Viral infectivity is a measure of the ability of the virus to enter the host cell and exploit its resources to replicate and produce additional infectious viral particles.

Instead of targeting the virus itself, these nanosponges are designed to protect the healthy cells the virus invades.

“Traditionally, drug developers for infectious diseases dive deep on the details of the pathogen in order to find druggable targets. Our approach is different. We only need to know what the target cells are. And then we aim to protect the targets by creating biomimetic decoys,” said Liangfang Zhang, a nanoengineering professor at the UC San Diego Jacobs School of Engineering.

His lab first created this biomimetic nanosponge platform more than a decade ago and has been developing it for a wide range of applications ever since [emphasis mine]. When the novel coronavirus appeared, the idea of using the nanosponge platform to fight it came to Zhang “almost immediately,” he said.

In addition to the encouraging data on neutralizing the virus in cell culture, the researchers note that nanosponges cloaked with fragments of the outer membranes of macrophages could have an added benefit: soaking up inflammatory cytokine proteins, which are implicated in some of the most dangerous aspects of COVID-19 and are driven by immune response to the infection.

Making and testing COVID-19 nanosponges

Each COVID-19 nanosponge–a thousand times smaller than the width of a human hair–consists of a polymer core coated in cell membranes extracted from either lung epithelial type II cells or macrophage cells. The membranes cover the sponges with all the same protein receptors as the cells they impersonate–and this inherently includes whatever receptors SARS-CoV-2 uses to enter cells in the body.

The researchers prepared several different concentrations of nanosponges in solution to test against the novel coronavirus. To test the ability of the nanosponges to block SARS-CoV-2 infectivity, the UC San Diego researchers turned to a team at Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) to perform independent tests. In this BSL-4 lab–the highest biosafety level for a research facility–the researchers, led by Anthony Griffiths, associate professor of microbiology at Boston University School of Medicine, tested the ability of various concentrations of each nanosponge type to reduce the infectivity of live SARS-CoV-2 virus–the same strains that are being tested in other COVID-19 therapeutic and vaccine research.

At a concentration of 5 milligrams per milliliter, the lung cell membrane-cloaked sponges inhibited 93% of the viral infectivity of SARS-CoV-2. The macrophage-cloaked sponges inhibited 88% of the viral infectivity of SARS-CoV-2. Viral infectivity is a measure of the ability of the virus to enter the host cell and exploit its resources to replicate and produce additional infectious viral particles.

“From the perspective of an immunologist and virologist, the nanosponge platform was immediately appealing as a potential antiviral because of its ability to work against viruses of any kind. This means that as opposed to a drug or antibody that might very specifically block SARS-CoV-2 infection or replication, these cell membrane nanosponges might function in a more holistic manner in treating a broad spectrum of viral infectious diseases. I was optimistically skeptical initially that it would work, and then thrilled once I saw the results and it sunk in what this could mean for therapeutic development as a whole,” said Anna Honko, a co-first author on the paper and a Research Associate Professor, Microbiology at Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL).

In the next few months, the UC San Diego researchers and collaborators will evaluate the nanosponges’ efficacy in animal models. The UC San Diego team has already shown short-term safety in the respiratory tracts and lungs of mice. If and when these COVID-19 nanosponges will be tested in humans depends on a variety of factors, but the researchers are moving as fast as possible.

“Another interesting aspect of our approach is that even as SARS-CoV-2 mutates, as long as the virus can still invade the cells we are mimicking, our nanosponge approach should still work. I’m not sure this can be said for some of the vaccines and therapeutics that are currently being developed,” said Zhang.

The researchers also expect these nanosponges would work against any new coronavirus or even other respiratory viruses, including whatever virus might trigger the next respiratory pandemic.

Mimicking lung epithelial cells and immune cells

Since the novel coronavirus often infects lung epithelial cells as the first step in COVID-19 infection, Zhang and his colleagues reasoned that it would make sense to cloak a nanoparticle in fragments of the outer membranes of lung epithelial cells to see if the virus could be tricked into latching on it instead of a lung cell.

Macrophages, which are white blood cells that play a major role in inflammation, also are very active in the lung during the course of a COVID-19 illness, so Zhang and colleagues created a second sponge cloaked in macrophage membrane.

The research team plans to study whether the macrophage sponges also have the ability to quiet cytokine storms in COVID-19 patients.

“We will see if the macrophage nanosponges can neutralize the excessive amount of these cytokines as well as neutralize the virus,” said Zhang.

Using macrophage cell fragments as cloaks builds on years of work to develop therapies for sepsis using macrophage nanosponges.

In a paper published in 2017 in Proceedings of the National Academy of Sciences, Zhang and a team of researchers at UC San Diego showed that macrophage nanosponges can safely neutralize both endotoxins and pro-inflammatory cytokines in the bloodstream of mice. A San Diego biotechnology company co-founded by Zhang called Cellics Therapeutics is working to translate this macrophage nanosponge work into the clinic.

A potential COVID-19 therapeutic The COVID-19 nanosponge platform has significant testing ahead of it before scientists know whether it would be a safe and effective therapy against the virus in humans, Zhang cautioned [emphasis mine]. But if the sponges reach the clinical trial stage, there are multiple potential ways of delivering the therapy that include direct delivery into the lung for intubated patients, via an inhaler like for asthmatic patients, or intravenously, especially to treat the complication of cytokine storm.

A therapeutic dose of nanosponges might flood the lung with a trillion or more tiny nanosponges that could draw the virus away from healthy cells. Once the virus binds with a sponge, “it loses its viability and is not infective anymore, and will be taken up by our own immune cells and digested,” said Zhang.

“I see potential for a preventive treatment, for a therapeutic that could be given early because once the nanosponges get in the lung, they can stay in the lung for some time,” Zhang said. “If a virus comes, it could be blocked if there are nanosponges waiting for it.”

Growing momentum for nanosponges

Zhang’s lab at UC San Diego created the first membrane-cloaked nanoparticles over a decade ago. The first of these nanosponges were cloaked with fragments of red blood cell membranes. These nanosponges are being developed to treat bacterial pneumonia and have undergone all stages of pre-clinical testing by Cellics Therapeutics, the San Diego startup cofounded by Zhang. The company is currently in the process of submitting the investigational new drug (IND) application to the FDA for their lead candidate: red blood cell nanosponges for the treatment of methicillin-resistant staphylococcus aureus (MRSA) pneumonia. The company estimates the first patients in a clinical trial will be dosed next year.

The UC San Diego researchers have also shown that nanosponges can deliver drugs to a wound site; sop up bacterial toxins that trigger sepsis; and intercept HIV before it can infect human T cells.

The basic construction for each of these nanosponges is the same: a biodegradable, FDA-approved polymer core is coated in a specific type of cell membrane, so that it might be disguised as a red blood cell, or an immune T cell or a platelet cell. The cloaking keeps the immune system from spotting and attacking the particles as dangerous invaders.

“I think of the cell membrane fragments as the active ingredients. This is a different way of looking at drug development,” said Zhang. “For COVID-19, I hope other teams come up with safe and effective therapies and vaccines as soon as possible. At the same time, we are working and planning as if the world is counting on us.”

I wish the researchers good luck. For the curious, here’s a link to and a citation for the paper,

Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity by Qiangzhe Zhang, Anna Honko, Jiarong Zhou, Hua Gong, Sierra N. Downs, Jhonatan Henao Vasquez, Ronnie H. Fang, Weiwei Gao, Anthony Griffiths, and Liangfang Zhang. Nano Lett. 2020, XXXX, XXX, XXX-XXX DOI: https://doi.org/10.1021/acs.nanolett.0c02278 Publication Date:June 17, 2020 Copyright © 2020 American Chemical Society

This paper appears to be open access.

Here, too, is the Cellics Therapeutics website.

*University of California as San Diego corrected to University of California at San Diego on Dec. 30, 2020.

Bionic pancreas tested at home

This news about a bionic pancreas must be exciting for diabetics as it would eliminate the need for constant blood sugar testing throughout the day. From a Dec. 19, 2016 Massachusetts General Hospital news release (also on EurekAlert), Note: Links have been removed,

The bionic pancreas system developed by Boston University (BU) investigators proved better than either conventional or sensor-augmented insulin pump therapy at managing blood sugar levels in patients with type 1 diabetes living at home, with no restrictions, over 11 days. The report of a clinical trial led by a Massachusetts General Hospital (MGH) physician is receiving advance online publication in The Lancet.

“For study participants living at home without limitations on their activity and diet, the bionic pancreas successfully reduced average blood glucose, while at the same time decreasing the risk of hypoglycemia,” says Steven Russell, MD, PhD, of the MGH Diabetes Unit. “This system requires no information other than the patient’s body weight to start, so it will require much less time and effort by health care providers to initiate treatment. And since no carbohydrate counting is required, it significantly reduces the burden on patients associated with diabetes management.”

Developed by Edward Damiano, PhD, and Firas El-Khatib, PhD, of the BU Department of Biomedical Engineering, the bionic pancreas controls patients’ blood sugar with both insulin and glucagon, a hormone that increases glucose levels. After a 2010 clinical trial confirmed that the original version of the device could maintain near-normal blood sugar levels for more than 24 hours in adult patients, two follow-up trials – reported in a 2014 New England Journal of Medicine paper – showed that an updated version of the system successfully controlled blood sugar levels in adults and adolescents for five days.  Another follow-up trial published in The Lancet Diabetes and Endocrinology in 2016  showed it could do the same for children as young as 6 years of age.

While minimal restrictions were placed on participants in the 2014 trials, participants in both spent nights in controlled settings and were accompanied at all times by either a nurse for the adult trial or remained in a diabetes camp for the adolescent and pre-adolescent trials. Participants in the current trial had no such restrictions placed upon them, as they were able to pursue normal activities at home or at work with no imposed limitations on diet or exercise. Patients needed to live within a 30-minute drive of one of the trial sites – MGH, the University of Massachusetts Medical School, Stanford University, and the University of North Carolina at Chapel Hill – and needed to designate a contact person who lived with them and could be contacted by study staff, if necessary.

The bionic pancreas system – the same as that used in the 2014 studies – consisted of a smartphone (iPhone 4S) that could wirelessly communicate with two pumps delivering either insulin or glucagon. Every five minutes the smartphone received a reading from an attached continuous glucose monitor, which was used to calculate and administer a dose of either insulin or glucagon. The algorighms controlling the system were updated for the current trial to better respond to blood sugar variations.

While the device allows participants to enter information about each upcoming meal into a smartphone app, allowing the system to deliver an anticipatory insulin dose, such entries were optional in the current trial. If participants’ blood sugar dropped to dangerous levels or if the monitor or one of the pumps was disconnected for more than 15 minutes, the system would alerted study staff, allowing them to check with the participants or their contact persons.

Study participants were adults who had been diagnosed with type 1 diabetes for a year or more and had used an insulin pump to manage their care for at least six months. Each of 39 participants that finished the study completed two 11-day study periods, one using the bionic pancreas and one using their usual insulin pump and any continous glucose monitor they had been using. In addition to the automated monitoring of glucose levels and administered doses of insulin or glucagon, participants completed daily surveys regarding any episodes of symptomatic hypoglycemia, carbohydrates consumed to treat those episodes, and any episodes of nausea.

On days when participants were on the bionic pancreas, their average blood glucose levels were significantly lower – 141 mg/dl versus 162 mg/dl – than when on their standard treatment. Blood sugar levels were at levels indicating hypoglycemia (less than 60 mg/dl) for 0.6 percent of the time when participants were on the bionic pancreas, versus 1.9 percent of the time on standard treatment. Participants reported fewer episodes of symptomatic hypoglycemia while on the bionic pancreas, and no episodes of severe hypoglycemia were associated with the system.

The system performed even better during the overnight period, when the risk of hypoglycemia is particularly concerning. “Patients with type 1 diabetes worry about developing hypoglycemia when they are sleeping and tend to let their blood sugar run high at night to reduce that risk,” explains Russell, an assistant professor of Medicine at Harvard Medical School. “Our study showed that the bionic pancreas reduced the risk of overnight hypoglycemia to almost nothing without raising the average glucose level. In fact the improvement in average overnight glucose was greater than the improvement in average glucose over the full 24-hour period.”

Damiano, whose work on this project is inspired by his own 17-year-old son’s type 1 diabetes, adds, “The availability of the bionic pancreas would dramatically change the life of people with diabetes by reducing average glucose levels – thereby reducing the risk of diabetes complications – reducing the risk of hypoglycemia, which is a constant fear of patients and their families, and reducing the emotional burden of managing type 1 diabetes.” A co-author of the Lancet report, Damiano is a professor of Biomedical Engineering at Boston University.

The BU patents covering the bionic pancreas have been licensed to Beta Bionics, a startup company co-founded by Damiano and El-Khatib. The company’s latest version of the bionic pancreas, called the iLet, integrates all components into a single unit, which will be tested in future clinical trials. People interested in participating in upcoming trials may contact Russell’s team at the MGH Diabetes Research Center in care of Llazar Cuko (LCUKO@mgh.harvard.edu ).

Here`s a link to and a citation for the paper,

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial by Firas H El-Khatib, Courtney Balliro, Mallory A Hillard, Kendra L Magyar, Laya Ekhlaspour, Manasi Sinha, Debbie Mondesir, Aryan Esmaeili, Celia Hartigan, Michael J Thompson, Samir Malkani, J Paul Lock, David M Harlan, Paula Clinton, Eliana Frank, Darrell M Wilson, Daniel DeSalvo, Lisa Norlander, Trang Ly, Bruce A Buckingham, Jamie Diner, Milana Dezube, Laura A Young, April Goley, M Sue Kirkman, John B Buse, Hui Zheng, Rajendranath R Selagamsetty, Edward R Damiano, Steven J Russell. Lancet DOI: http://dx.doi.org/10.1016/S0140-6736(16)32567-3  Published: 19 December 2016

This paper is behind a paywall.

You can find out more about Beta Bionics and iLet here.